Rethinking regulations. LTC leaders discuss nursing home law with a regulatory reform advocate. Panel discussion.
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to P Willging.
Explore the source record for details and available documents.
Anticipating the needs of aging baby boomers and responding to market demands for consumer choice and low-cost care, long-term care providers are changing the way they do business. As part of that change, they are offering new and, in some cases, more complex services at both the high and low end of the spectrum. At the high acuity end, long-term care providers are delivering hospital-like subacute care to increasing numbers of patients at roughly half the costs of providing the same care in hospitals. At the low acuity end, providers are offering new assisted living services, as well as a full range of community-based long-term care. At the same time, traditional nursing facilities continue to meet the needs of chronically ill elderly and people of all ages needing rehabilitative care. These changes point to a shifting role for physicians (and especially medical directors) in the long-term care setting.
Explore the source record for details and available documents.
Provider spoke with corporate executives about the trends changing the face of long term care. They talked about a variety of tools--quality initiatives, diversification, financing, and staff recruitment--that are having an impact on the industry.
Explore the source record for details and available documents.
During the past 15 months, long term care providers have worked diligently to implement the nursing facility reform provisions of the Omnibus Budget Reconciliation Act of 1987 (OBRA). Other significant events, such as the release of final rules clarifying OBRA and state funding shortfalls, promise to keep the industry busy in the coming years. Provider interviewed leaders of the American Health Care Association (AHCA) to assess the present state of the industry and talk about the Association's goals.
Fungal sinusitis in the immunocompromised child is an aggressive, invasive process that may result in a fatal outcome if not diagnosed early. As a result of increasing use of bone marrow transplantation and new cytotoxic chemotherapeutic agents resulting in severe agranulocytopenia, more patients have become susceptible to fungal sinus disease. Functional endoscopic sinus surgery has emerged recently as an important surgical modality in the treatment of sinus disease in adults and children. Use of this technique in immunosuppressed children has allowed early diagnosis of fungal sinonasal disease, resulting in earlier surgical intervention. The high-quality fiberoptic capability of nasal endoscopes allows very detailed visualization of the internal anatomy of the nose and detects early mucosal changes as a result of intranasal fungal disease. Our experience using functional endoscopic sinus surgery in immunocompromised children over an 18-month period is reviewed. Our philosophy for diagnosis and management of immunocompromised children with suspected fungal sinonasal disease is discussed.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.